The Indonesian Drug and Food Control Agency (BPOM) said it will penalize two pharmaceutical companies after ethylene glycol (EG) and diethylene glycol (DEG) were detected in their syrups.
BPOM issues emergency use authorization (UEA) upon evaluation on the safety and efficacy aspects of Sinopharm vaccine, which will be used as homologous booster.
Merah Putih vaccine has concluded its preclinical trial on animal and is currently awaiting phase one of clinical trial planned for early February.
Ministry of Health estimates hospitalization to be lower as symptoms have been found to be considerably mild.
The Agency issued emergency use authorization (UEA) after evaluation with experts found the vaccines to have met the standards and requirements.